Jane Street’s CervoMed CRVO Stock Holding History

Jane Street’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$99.9K	Buy	32,231 +13,985	+77%	+$49.3K	﹤0.01%	10594
2026 Q1	$71.9K	Buy	18,246 +7,170	+65%	+$37.4K	﹤0.01%	10803
2025 Q4	$87.5K	Buy	+11,076	New	+$89K	﹤0.01%	10248
2025 Q3	–	Sell	-65,939	Closed	-$414K	–	10897
2025 Q2	$414K	Buy	+65,939	New	+$562K	﹤0.01%	7281
2022 Q2	–	Sell	-242	Closed	-$5K	–	9785
2022 Q1	$5K	Sell	242 -61	-20%	-$1.21K	﹤0.01%	10130
2021 Q4	$7K	Buy	+303	New	+$9.48K	﹤0.01%	9936
2021 Q3	–	Sell	-214	Closed	-$12K	–	10017
2021 Q2	$12K	Buy	+214	New	+$11.8K	﹤0.01%	9669
2020 Q3	–	Sell	-1,543	Closed	-$113K	–	7222
2020 Q2	$113K	Buy	+1,543	New	+$93.9K	﹤0.01%	6668
2018 Q4	–	Sell	-17	Closed	-$8K	–	5031
2018 Q3	$8K	Buy	+17	New	+$7.91K	﹤0.01%	4998

Other funds holding CRVO

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAM

Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TDC

Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

SAI

Savvy Advisors Inc New York $4.71B AUM 25.36% 1-Year Est. Return

Jane Street's CRVO Position: Q2 2026 in Review

Jane Street increased its CervoMed (CRVO) stake by 77% in Q2 2026, buying an estimated $49.3K and bringing the position to 32,231 shares worth $99.9K. The position accounts for ﹤0.01% of the portfolio, ranked #10594.

Jane Street first reported a position in CRVO in Q3 2018 and has held it in 9 quarters since. The position peaked at $414K in Q2 2025. 36 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

Jane Street held 32,231 shares of CervoMed worth $99.9K as of Q2 2026.
Jane Street bought 13,985 CervoMed shares in Q2 2026, an estimated $49.3K.
CervoMed made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10594 holding.
Jane Street first reported a position in CervoMed in Q3 2018 and has held it in 9 quarters since.
Jane Street's CervoMed position peaked at $414K in Q2 2025.
36 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.